慢性心力衰竭患者的临床表型和治疗反应
Daishiro Tatsuta1, Motoki Nakao1, Toshiyuki Nagai1
1Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
JACC. Advances
|July 18, 2025
概括
研究人员确定了8种不同的心力衰竭 (HF) 现象组,预后不同. 这种分类有助于风险分层和个性化治疗决策HF患者.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 基因组学就是基因组学.
背景情况:
- 关于临床意义上的心力衰竭 (HF) 现象组的数据有限.
- 了解与左心室 (LV) 喷射小部分的整个频谱的治疗反应相关的HF表型至关重要.
研究的目的:
- 为了识别不同的HF患者表型.
- 确定与这些表型相关的预后影响和治疗反应.
主要方法:
- 来自ELMSTAT-HF注册表的2,301名慢性HF患者的99个临床特征的潜在类别分析.
- 未来的多中心队列研究,主要结果是全因死亡和HF住院治疗.
- 随访时间中位数为597天.
主要成果:
- 确定了8个HF现象组,包括患有肥胖的年轻患者,较少结构异常,LV扩张或缩的年轻患者,患有透静功能障碍的老年患者,缺血性心肌病,晚期LV重塑和心房肌病.
- 在原始结局发生率中观察到显著的差异跨现象组 (P < 0.001).
- 现象组5 (老年,小LV,腹功能障碍) 显示,使用β-阻断剂或SGLT2抑制剂时,HF住院率增加.
结论:
- 确定了8个不同的HF现象组,具有不同的临床结果.
- 这种表型化方法使HF患者的风险分层更好.
- 这些发现可能有助于为心力衰竭管理量身定制临床决策.
相关概念视频
Heart Failure IV: Classification and Diagnostic Evaluation
33
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
33
Pathophysiology of Heart Failure
1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure V: Medical Management
26
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
26
Cardiomyopathy V: Interprofessional Care
35
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
35
Heart Failure II: Pathophysiology
45
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
45
Heart Failure Drugs: β-Blockers
435
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
435


